Cargando…

Patient Preferences for Topical Psoriasis Treatments are Diverse and Difficult to Predict

INTRODUCTION: Topicals are a mainstay in psoriasis vulgaris treatment and are used concomitantly even in patients receiving systemic therapy. Patient acceptance of topical treatment can impact adherence and, consequently, real-life effectiveness. This study aimed to identify patient preferences for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iversen, Lars, Jakobsen, Henny B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906113/ https://www.ncbi.nlm.nih.gov/pubmed/27125383 http://dx.doi.org/10.1007/s13555-016-0119-4

Ejemplares similares

Treatment Preferences in Young Adults with Moderate to Severe Psoriasis: A Qualitative Study from the Nordic Countries
por: Balieva, Flora Nicol, et al.
Publicado: (2023)

Patient preference for biologic treatments of psoriasis in Japan
por: Tada, Yayoi, et al.
Publicado: (2019)

Patient Preference for Biologic Treatments of Psoriasis in the Chinese Setting
por: Lang, Yitian, et al.
Publicado: (2022)

Sex-related impairment and patient needs/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care
por: da Silva, Neuza, et al.
Publicado: (2020)

Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis
por: Alcusky, Matthew, et al.
Publicado: (2017)

Observational Study of Topical Imiquimod Immunotherapy in the Treatment of Difficult Lentigo Maligna
por: Craythorne, E.E., et al.
Publicado: (2008)

Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids
por: Svendsen, Mathias Tiedemann, et al.
Publicado: (2016)

Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations
por: Bhosle, Monali, et al.
Publicado: (2009)

Adherence to Topical Therapies for the Treatment of Psoriasis: Surveys of Physicians and Patients
por: Choi, Jee Woong, et al.
Publicado: (2017)

Topical Tretinoin in the Treatment of Nail Psoriasis
por: Grover, Chander, et al.
Publicado: (2022)

Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies
por: Stein Gold, Linda, et al.
Publicado: (2023)

Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas
por: Cacciapuoti, Sara, et al.
Publicado: (2023)

Evidence and Suggested Therapeutic Approach in Psoriasis of Difficult-to-treat Areas: Palmoplantar Psoriasis, Nail Psoriasis, Scalp Psoriasis, and Intertriginous Psoriasis
por: Sarma, Nilendu
Publicado: (2017)

Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL study
por: Hong, C‐H., et al.
Publicado: (2017)

Topical Therapies in Psoriasis
por: Torsekar, R., et al.
Publicado: (2017)

Topical Therapy in Psoriasis
por: Ahmed, SK Shahriar, et al.
Publicado: (2023)

Treatment of Psoriasis: Novel Approaches to Topical Delivery
por: Wollina, Uwe, et al.
Publicado: (2019)

Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment
por: Kromer, Christian, et al.
Publicado: (2015)

Old and New Biological Therapies for Psoriasis
por: Rønholt, Kirsten, et al.
Publicado: (2017)

Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis
por: Elgaard, Cathrine Dawn Büttner, et al.
Publicado: (2023)

Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature
por: Belinchón, I, et al.
Publicado: (2016)

Dimethyl Fumarate Targets MSK1, RSK1, 2 and IKKα/β Kinases and Regulates NF-κB /p65 Activation in Psoriasis: A Demonstration of the Effect on Peripheral Blood Mononuclear Cells, Drawn from Two Patients with Severe Psoriasis Before and After Treatment with Dimethyl Fumarate
por: Gesser, Borbala, et al.
Publicado: (2020)

Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP)
por: Duvetorp, A., et al.
Publicado: (2019)

Efficacy of Tildrakizumab for the Treatment of Difficult-to-Treat Areas: Scalp, Nail, Palmoplantar and Genital Psoriasis
por: Galluzzo, Marco, et al.
Publicado: (2022)

Brodalumab in the Treatment of Plaque Psoriasis Localized in Difficult-to-Treat Areas: A Narrative Review
por: Cannizzaro, Maria Vittoria, et al.
Publicado: (2023)

Efficacy of adding topical simvastatin to topical calcipotriol on improvement of cutaneous plaque psoriasis
por: Iraji, Fariba, et al.
Publicado: (2014)

Once-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulation
por: Shepherd, Jonisha, et al.
Publicado: (2013)

Comorbidity in Adult Psoriasis: Considerations for the Clinician
por: Daugaard, Christine, et al.
Publicado: (2022)

Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5–15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials
por: Iversen, Lars, et al.
Publicado: (2020)

Topical Immunotherapy with Diphenylcyclopropenone Is Effective and Preferred in the Treatment of Periungual Warts
por: Choi, Yunseok, et al.
Publicado: (2013)

A randomised controlled trial of topical Kanuka honey for the treatment of psoriasis
por: Fingleton, James, et al.
Publicado: (2014)

Exploration of and insights into advanced topical nanocarrier systems for the treatment of psoriasis
por: Zhang, Miao, et al.
Publicado: (2022)

Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients
por: Aschoff, Roland, et al.
Publicado: (2021)

Psoriasis and Topical Iranian Traditional Medicine
por: Atyabi, Akramosadat, et al.
Publicado: (2016)

Mechanisms of Action of Topical Corticosteroids in Psoriasis
por: Uva, Luís, et al.
Publicado: (2012)

Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis
por: Menter, Alan, et al.
Publicado: (2022)

General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach
por: Thaçi, Diamant, et al.
Publicado: (2020)

Comparative Efficacy and Patient Preference of Topical Anaesthetics in Dermatological Laser Treatments and Skin Microneedling
por: Chiang, Yi Zhen, et al.
Publicado: (2015)

Addressing challenges associated with long‐term topical treatment and benefits of proactive management in patients with psoriasis
por: Lebwohl, M., et al.
Publicado: (2021)

Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients
por: Schaarschmidt, Marthe-Lisa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fi346obk5i2ll1hdtb12e3fldn